Voriconazole: therapeutic review of a new azole antifungal (Q35917452)

11 August 2017

1 reference

title

Voriconazole: therapeutic review of a new azole antifungal (English)

1 reference

11 August 2017

1 reference

1

Raoul Herbrecht

1 reference

11 August 2017

1 August 2004

1 reference

Expert Review of Anti-infective Therapy

11 August 2017

1 reference

11 August 2017

2

1 reference

11 August 2017

4

1 reference

11 August 2017

485-497

1 reference

Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998.

11 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.485

Comparison of the modified Stokes' method of susceptibility testing with results obtained using MIC methods and British Society of Antimicrobial Chemotherapy breakpoints.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.485

Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.485

In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.485

Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance P

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.485

Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.485

Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.485

Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.485

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.485

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.485

A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.485

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.485

Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.485

Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.485

Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.485

Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.485

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.485

Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.485

21 January 2018

Identifiers

DOI

10.1586/14787210.2.4.485

1 reference

11 August 2017

1 reference

PubMed ID

15482215